Shoshanna Fischhoff

For Nurses Week, we wanted to spotlight two incredible nurses whose focus is in ALS, Sandy Lemkin and Jayna Duell.

The multi-award-winning thesis was written on work conducted in the NeuroNetwork for Emerging Therapies’s lab.

The New York Times interviewed Eva Feldman, M.D., Ph.D., for "10 Small Things Neurologists Wish You'd Do for Your Brain."

The podcast Factory Factory featured Eva L. Feldman, M.D., Ph.D., exploring preparing faculty for success in leadership positions.

Dr. Feldman spoke about the importance of researching clusters in ALS.

A new grant will fund study of an immune cell that may represent a potential target for treating the disease.

Research found that despite changes in guidelines for peripheral neuropathy testing, actual practices had not changed.

Celebrating the brain science happening at the NeuroNetwork for Emerging Therapies.

The American Neurological Association highlighted Eva L. Feldman, M.D., Ph.D.’s, past tenure as president.

Researcher observed that changes in metabolism was linked to ALS progression.

The move for Frances and Kenneth Eisenberg Emerging Scholar Kevin Chen, M.D., solidifies and furthers his research endeavors.

The American Brain Foundation presented Melissa Elafros, M.D., Ph.D., with the Mridha Spirit of Neurology Award for her work improving care for those most in need.

Five new board members share a personal experience with ALS and a commitment to advancing care and research for the devastating disease.

Dr. Feldman was interviewed by Health about research that says that "Weekend Warriors Can Still Reap Brain Health Benefits from Exercise."

The Mitchell B. Max Award for Neuropathic Pain was awarded to Brian Callaghan, M.D., M.S., by the American Academy of Neurology.